Oxford University will start human testing with a Covid-19 vaccine they developed from Thursday, the UK government said in a coronavirus press conference.
The vaccine project, which is being run by the Jenner Institute and Oxford Vaccine Group, will also receive a further £20 million in funding from the Government.
According to The New York Times, the researchers plan to carry out mid-stage efficacy trials of the vaccine. “They then plan to expand the trial group to older age groups later, and hope to run a final phase trial with around 5,000 volunteers in the late summer,” the report said. They scale it up to a million doses by September – and hundreds of millions by the end of the year.